SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical
MEDX ... anybody following?
An SI Board Since May 1996
Posts SubjectMarks Bans Symbol
2240 62 0 MEDX
Emcee:  Ed Offstein Type:  Unmoderated
Introduction Market Data Compact
Previous 25 | Next 25 | View Recent | Post Message
Go to reply# or date (mm/dd/yy):
ReplyMessage PreviewFromRecsPosted
1590Lerner has "agreed" to have some of his options repriced. Nothing majoIcebrg-12/22/2006
1589IDM Pharma (IDMI) to Reduce its Workforce by 20 Employees 12-21-2006 03:12:45 PMIcebrg-12/22/2006
1588For some reason, I thought they did get royalties as well on product licenses. LJM-12/20/2006
1587Thanks Erik. AshleyA.J. Mullen-12/20/2006
1586Yes, I held my nose when buying Medx. It seemed like a gift to the wife. She hA.J. Mullen-12/20/2006
1585Ashley, After the GSK-deal they hold just below 17 %. ErikIcebrg-12/20/2006
1584That's the thing that always killed me about medx. They spin out platform anrkrw-12/20/2006
1583Yeah, but ImClone got a lot more in upfront cash, as opposed to back end milestotuck-12/20/2006
1582Erik, what percentage of Genmab does Medarex own - prior to this dilution? I knA.J. Mullen-12/20/2006
1581GSK, Genmab Deal Tops All: $2.1B For Phase III Antibody By Randall Osborne West Icebrg-12/20/2006
1580Icebrg I can see that you are very active on the MEDX board here and are very kDG30dk-12/20/2006
1579I just made a post at medarexstock.com on the approval success rates and phase tDG30dk-12/19/2006
1578Me either - always thought they looked expensive. :-) Drakeman for CEO of the nigel bates-12/19/2006
1577Irwin Lerner must have been kind of busy during the last couple of months. He noIcebrg-12/19/2006
1576<i>Did you ever have stock in them</i> No, I have never held any stIcebrg-12/19/2006
1575Wow ! (Did you ever have stock in them, or just MEDX ?)nigel bates-12/19/2006
1574ANNOUNCEMENT OF ADDITIONAL DETAILS CONCERNING THE ISSUE OF SHARES TO GLAXOSMITHKIcebrg-12/19/2006
1573Glaxo signs $2.1 bln deal for Genmab lead drug Tue Dec 19, 2006 2:45am ET LONDOscaram(o)uche-12/19/2006
1572GLAXOSMITHKLINE AND GENMAB ENTER GLOBAL AGREEMENT FOR HUMAX-CD20 [Comment: Oh, Icebrg-12/19/2006
1571GENMAB ANNOUNCES AMG 714 DEVELOPMENT UPDATE Copenhagen, Denmark; December 15, 2Icebrg-12/15/2006
1570NEW YORK, Dec 14 (Reuters) - Bristol-Myers Squibb said on Thursday it could seekIcebrg-12/14/2006
1569Genmab Announces HuMax-ZP3 Cancer Program Wednesday December 13, 3:13 am ET COPIcebrg-12/13/2006
1568Genmab pares down list of potential new partners - 11/12/2006 The chief executiIcebrg-12/12/2006
1567GENMAB ANNOUNCES ADDITIONAL POSITIVE RESULTS IN HUMAX-CD20 CLL PHASE I/II STUDY Icebrg-12/11/2006
1566Ipilimumab (MDX-010) Safety and Clinical Response Data in Lymphomas and Leukemianigel bates-12/11/2006
Previous 25 | Next 25 | View Recent | Post Message
Go to reply# or date (mm/dd/yy):
HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News